Concepedia
Statistics
Publications
9
Citations
250
H-Index
Active since
2013
Affiliations
China Medical University(Current)
Hebei University of Engineering
Affiliated Hospital of Hebei University
Dalian Medical University
First Hospital of China Medical University
Weiguang Liu is an author at China Medical University specializing in oncology, cancer cell signaling, and molecular oncology.
Publications per year
2013–2024
TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
Weiguang Liu, Guanglei Chen, Lisha Sun et al. · Frontiers in Oncology · 2019 · 61 citations · Full text
Medicine, Cancer Biology, Oncology +17
FAM49B promotes breast cancer proliferation, metastasis, and chemoresistance by stabilizing ELAVL1 protein and regulating downstream Rab10/TLR4 pathway
Yanhui Li, Yue Xiong, Zhen Wang et al. · Cancer Cell International · 2021 · 30 citations · Full text
ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells
Duote Cai, Hua Jin, Qixing Xiong et al. · Molecular and Cellular Biochemistry · 2013 · 29 citations
Life Sciences, Cell Biology, Oncology +17
TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
Weiguang Liu, Jianjun Han, Sufang Shi et al. · Cancer Cell International · 2019 · 29 citations · Full text
Medicine, Molecular Biology, Oncology +16
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions
Qing Deng, Priya Lakra, Panhong Gou et al. · Cancer Cell · 2024 · 29 citations · Full text
Life Sciences, Molecular Biology, Oncology +15
1–5 of 9